These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4231853)

  • 1. [Antihypertensive and catecholamine-discharging effects of alpha-methyltyramine and alpha-methyloctopamine].
    Maître L; Brunner H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):40-1. PubMed ID: 4231853
    [No Abstract]   [Full Text] [Related]  

  • 2. Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine.
    Thoenen H; Gerold M; Haefely W; Huerlimann A
    Experientia; 1968 Feb; 24(2):158-9. PubMed ID: 4384506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variations in the catecholamine content of the rat brain and heart after administration of alpha-methyldopa, clonidine and diazoxide].
    Albano V; Bellanca L; Latteri S; Valdes L
    Boll Soc Ital Biol Sper; 1977 Nov; 53(22):2036-40. PubMed ID: 603708
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
    Kroneberg G; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of adrenal catecholamines for reflex cardiovascular counterregulation in rats with renal hypertension].
    Brunner H; Hedwall PR
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(5):387-96. PubMed ID: 4392043
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between the changes on blood pressure response and the cardiac catecholamine level after single and repeated administrations of tyramine and methamphetamine in rats.
    Takasaki K; Nishizawa T; Igisu T; Kaneko M
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):150-60. PubMed ID: 4775933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antihypertensive and noradrenaline-depleting effect of alpha methyl tyramine and alpha methyl octapamine in the rat].
    Maître L; Brunner H
    Biochem Pharmacol; 1971 Feb; 20(2):351-9. PubMed ID: 5150136
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.
    Botton I; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 May; 152(2):243-50. PubMed ID: 5944368
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effect of methyldopa in metacorticoid immunosympathectomized rats.
    Varma DR
    J Pharm Pharmacol; 1967 Jan; 19(1):61-2. PubMed ID: 4382180
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the catecholamine content and cyclic AMP concentration in the rat brain and heart after administration of alpha-methyldopa].
    Albano V; Antona A; Bellanca L; Latteri S; Valdes L; Latteri MT
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):427-31. PubMed ID: 181037
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of dimethyl trilobine iodide (DTI) on the blood pressure of unanesthetized and acute renal hypertensive rats].
    Liu JB; Che XP
    Yao Xue Xue Bao; 1984 Oct; 19(10):790-1. PubMed ID: 6544032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypotensive drugs and tissue noradrenaline].
    Jori A; Mortari A; Sioli G; Valzelli L
    Boll Soc Ital Biol Sper; 1964 Nov; 40(22):1421-3. PubMed ID: 5876862
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of Go-1002.
    Grewal RS; Kaul CL; David J
    J Pharmacol Exp Ther; 1968 Apr; 160(2):268-76. PubMed ID: 4384786
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of cobalt nitrosopentacyanoferrate 3].
    Caujolle F; Pham-Huu-Chanh ; Lecointe P
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):487-95. PubMed ID: 5684258
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
    van Zwieten PA
    Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo effects of antihypertensive drugs on PG metabolism in different organs.
    Förster W; Taube C; Block HU; Fahr A; Pönicke K; Mentz P; Giebler C; Bayer BL
    Adv Prostaglandin Thromboxane Res; 1980; 7():811-3. PubMed ID: 7369044
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect.
    Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):412-9. PubMed ID: 4397179
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertension and anti-cardiovascular remodeling by phenylalanine in spontaneously hypertensive rats: effectiveness and mechanisms.
    Zhao G; Li Z; Gu T
    Chin Med J (Engl); 2001 Mar; 114(3):270-4. PubMed ID: 11780312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.